The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TBCRC-010: Phase I/II study of dasatinib in combination with zoledronic acid (ZA) for the treatment of breast cancer bone metastasis (MBC-bone).
 
Zahi Ibrahim Mitri
No Relationships to Disclose
 
Rita Nanda
No Relationships to Disclose
 
Kimberly L. Blackwell
No Relationships to Disclose
 
Colleen Costelloe
No Relationships to Disclose
 
Ilona Hood
No Relationships to Disclose
 
Abenaa M. Brewster
No Relationships to Disclose
 
Nuhad K. Ibrahim
No Relationships to Disclose
 
Kimberly Higginbotham Koenig
No Relationships to Disclose
 
Gabriel N. Hortobagyi
Consulting or Advisory Role - Amgen; Antigen Express; Galena Biopharma; Genentech; Novartis; Peregrine Pharmaceuticals; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Catherine H. Van Poznak
Research Funding - Amgen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Mothaffar F. Rimawi
Research Funding - GlaxoSmithKline (Inst)
 
Stacy L. Moulder
No Relationships to Disclose